IRadimed Corporation (NasdaqCM:IRMD) announces a share repurchase program. Under the program, the company will repurchase up to $10 million worth of its common stock. Purchases will be made in open market transactions effected through a broker-dealer at prevailing market prices, in block trades, or in privately negotiated transactions.

Any repurchased shares will be available for general corporate purposes. The company intends to use cash on hand, investments and cash generated from operations to fund the share repurchase program. The timing and amount of the repurchases will be subject to applicable legal requirements including federal and state securities laws.

The program will run through January 28, 2017.